Delivery Order 36C25222D0009-36C25223N0191
- Not listed
- This is a $497,301.00 firm-fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) to Myriad Genetics Inc. for Prolaris genetic testing services for the VA Long Beach Healthcare System. The contract has a period of performance from October 1, 2024 to September 30, 2027, with no set-aside designation. The original solicitation was a full and open competition for Prolaris send-out testing kits and services to test for prostate cancer. The contract will provide these...
- This $122,672 federal contract was awarded by the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract is for the delivery of Prolaris prostate cancer testing services, which analyze genetic information to determine disease progression risks and support clinical treatment decisions. The contract was competitively awarded without a set-aside designation, and is structured...
- This federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration was granted to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide Prolaris prostate cancer testing services. The firm fixed price contract, valued at $14,994.00, is a Blanket Purchase Agreement (BPA) call to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network (VISN) 19 in Salt Lake...
- This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
- This federal contract award is for Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to provide its Prolaris prostate cancer genetic testing services to the U.S. Department of Veterans Affairs (VA). The contract, with a ceiling value of $6,000.00, is a firm fixed-price delivery order that supports disease risk stratification and treatment planning for veterans served by the VA healthcare system, including the Salt Lake City VA Medical Center. Myriad Genetics Inc. has been...
- This federal contract award is for the delivery of Prolaris genetic testing services to the U.S. Department of Veterans Affairs (VA). The prime contractor is Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. that specializes in personalized medicine and genetic testing. The contract was awarded by the VA's Veterans Integrated Service Network 12 (VISN 12) and the VA Salt Lake City Health Care System. It includes two Indefinite Delivery Vehicles (IDVs) - an Indefinite Delivery...
- This federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., is for a Firm Fixed Price Purchase Order of $7,946.32 to provide MYRIAD GENETIC TESTING services. The contract, awarded by the Defense Health Agency, has an ultimate completion date of February 25, 2017. Myriad Genetic Laboratories Inc. is a for-profit company that specializes in genetic testing and precision medicine services. The primary service provided under this contract is the Prolaris...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract is for the provision of Prolaris prostate cancer testing services to the VA's Salt Lake City VA Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $2,499. The contract has no set-aside designation. This BPA is part of a larger Indefinite Delivery Vehicle (IDV) awarded by the VA's...
- The Department of Veterans Affairs Veterans Health Administration awarded a $5,984 firm fixed price delivery order to Myriad Genetic Laboratories Inc. for ProLaris testing. The parent company of the prime contractor is Myriad Genetics Inc. The single award was made on December 1, 2021 with a completion date of November 30, 2022. The place of performance is located in Emigration Canyon, Utah. No set aside designation was used for this contract to provide genetic testing services through the VHA's...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a Blanket Purchase Agreement Call contract to Myriad Genetic Laboratories Inc. for $0.00 potential value. Under the contract, Myriad Genetic Laboratories Inc. will provide Prolaris prostate cancer testing services to the agency through April 30, 2026. As the parent company, Myriad Genetics Inc. will oversee work conducted by Myriad Genetic Laboratories Inc. No set-aside designation...
- 36C25222D0009Indefinite Delivery Contract
- 36C25222D0009-36C25223N0191Delivery Order
This is a firm fixed price delivery order awarded to Myriad Genetic Laboratories Inc., a leading genetic testing and precision medicine company, by the Department of Veterans Affairs (VA) Veterans Health Administration. The $10,982 contract is for the provision of Prolaris prostate cancer testing services to support disease risk stratification and treatment planning for veterans served by the VA's Veterans Integrated Service Network 12. Myriad Genetic Laboratories previously held a $149,600 indefinite delivery contract with the VA's Veterans Integrated Service Network 12 to provide Prolaris testing through November 2026, as well as a $74,970 blanket purchase agreement with Veterans Integrated Service Network 19 to deliver Prolaris prostate cancer testing services to the VA Salt Lake City Health Care System through April 2026. These contract vehicles assist in the diagnosis, risk assessment, and care management for veterans receiving cancer treatment through the VA health system. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($19k) | 4/9/24 | |
| Not listed | Not listed | $29.9k | 11/23/22 |